Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SmithKline Beckman

Executive Summary

Chairman Robert Dee, 62, to retire and step down from the board on April 22 after 38 years with the company. Dee joined SmithKline as a trainee in 1948 and was elected president in 1972 and chairman in 1976. With the exception of C. Mehlon Kline (1945-1958), Dee served as SmithKline chairman longer than anyone in this century. Dee was the top officer at SmithKline during the Tagamet development era. In recent years, Dee has participated actively in D.C. lobbying. Dee, for example, chaired PMA's tax committee from 1983-86, helping to preserve Section 936 in the most recent tax bill. He was also active in broader business policy issues, as a member of the Business Roundtable from 1976-82 and, most recently, as chairman of the National Association of Manufacturers. Dee's departure sets the stage for titular progression at SmithKline. The company has announced that President and CEO Henry Wendt will succeed Dee as chairman; recently-appointed Chief Operating Officer George Ebright appears in line to assume presidency.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS011412

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel